Sort   by:  
 Page size 
MetabolomicsFecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial

Fecal microbiota transplantation (FMT) represents a potential strategy to overcome resistance to immune checkpoint inhibitors in patients with refractory melanoma; however, the role of FMT in first-line treatment settings has not been evaluated. We conducted a multicenter phase I trial combining ...

2025-02-27 | MTBLS711 | MetaboLights
MetabolomicsMetabolic phenotyping of urine from a dementia research cohort
To better understand the molecular mechanisms underpinning physiological variation in human populations, metabolic phenotyping approaches are increasingly being applied to studies involving hundreds and thousands of biofluid samples. Hyphenated ultra-performance liquid chromatography-mass spectromet...
2022-03-01 | MTBLS719 | MetaboLights
UnknownType 2 immune responses are associated with less severe COVID-19 in a hospitalized cohort.
Not available
S-EPMC12284355 | biostudies-literature
UnknownHost-microbe multiomic profiling reveals age-dependent immune dysregulation associated with COVID-19 immunopathology.
Not available
S-EPMC11931290 | biostudies-literature
UnknownHost-microbe multiomic profiling identifies distinct COVID-19 immune dysregulation in solid organ transplant recipients.
Not available
S-EPMC11723965 | biostudies-literature
UnknownPhenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study.
Not available
S-EPMC9359694 | biostudies-literature
UnknownMachine learning models predict long COVID outcomes based on baseline clinical and immunologic factors.
Not available
S-EPMC12764860 | biostudies-literature
UnknownFeatures of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study.
Not available
S-EPMC10764789 | biostudies-literature
UnknownWhen the wild things are: Defining mammalian diel activity and plasticity.
Not available
S-EPMC11864191 | biostudies-literature
UnknownThe major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
Not available
S-EPMC3235490 | biostudies-literature
Sort   by:  
 Page size